Carregant...
Public-private partnerships as driving forces in the quest for innovative medicines
BACKGROUND: Despite progress in translational research, we are still falling short in developing the innovative medicines required to address major public health needs. Furthermore, the failure rate, time, and cost required for registration of a new drug are pushing the economics of the industry to...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564715/ https://ncbi.nlm.nih.gov/pubmed/23369569 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2001-1326-2-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|